According to Adaptimmune Therapeutics's latest financial reports the company's current earnings (TTM) are -S$98.17 M. In 2023 the company made an earning of -S$0.15 B an increase over its 2022 earnings that were of -S$0.22 B.The earnings displayed on this page is the company's Pretax Income.